Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Radiation, Procedure
  • Participants: 100
  • Start Date: January 18, 2021
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 60
  • Start Date: October 22, 2020
Circulating Cancer Cells / Macrophage HYbrid Cells in Patients With Sarcoma?
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological, Procedure, Radiation, Drug
  • Participants: 25
  • Start Date: October 14, 2020
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Other
  • Participants: 28
  • Start Date: September 30, 2019
A Pilot Study Examining the Impact of the Jak1 Inhibitor Itacitinib on the Sarcoma Tumor Immune Microenvironment
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Genetic
  • Participants: 90
  • Start Date: July 24, 2019
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 70
  • Start Date: June 26, 2019
Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 57
  • Start Date: May 13, 2019
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Clinical Trial
  • Status: Recruiting
  • Participants: 10000
  • Start Date: January 28, 2019
Natural History and Biospecimen Acquisition Study for Children and Adults With Rare Solid Tumors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological
  • Participants: 18
  • Start Date: September 13, 2018
Phase I Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ NYESO-1-Specific T Cells and the NY-ESO-1 Immunostimulatory Agents LV305 or CMB305 for Patients With Sarcoma
Showing 1-12 of 31